All stock lists Unlock the score
Rapport Therapeutics, Inc. (NASDAQ:RAPP)
US · Delayed Price · Currency is USD
25.93-0.60 (-2.26%)
Insider Score
/ 100
RAPP Insider Score
Rapport Therapeutics, Inc. has a live Insider Score.
Scored on 6 qualifying trades from 5 insiders in the last 90 days.
RAPP Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 0.00 | 20.00 M | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 20.00 M | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A Expense | 9.39 M | 11.50 M | 8.25 M | 7.71 M | 6.82 M | 7.54 M |
| R&D Expense | 51.41 M | 32.72 M | 30.26 M | 22.28 M | 22.68 M | 19.57 M |
| Operating Expenses | 60.81 M | 44.22 M | 38.51 M | 29.99 M | 29.50 M | 27.11 M |
| Operating Income | -60.81 M | -24.21 M | -38.51 M | -29.99 M | -29.50 M | -27.11 M |
| Pretax Income | -56.62 M | -19.86 M | -33.76 M | -26.93 M | -26.73 M | -24.06 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -56.62 M | -19.86 M | -33.76 M | -26.93 M | -26.73 M | -24.06 M |
| EPS (Basic) | -1.19 | -0.42 | -0.72 | -0.71 | -0.75 | -0.68 |
| EPS (Diluted) | -1.19 | -0.42 | -0.72 | -0.71 | -0.75 | -0.68 |
| Shares Outstanding | 47.47 M | 47.24 M | 46.98 M | 37.93 M | 35.44 M | 19.29 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.